2025-07-05 - Analysis Report
Okay, here's an analysis of Transmedics Group Inc (TMDX) based on the provided data. The report is structured with key figures first, followed by analysis, and is written in English.

## Transmedics Group Inc (TMDX) Analysis

**Transmedics Group Inc: Revolutionizing organ transplant therapy with its Organ Care System (OCS).**

### 1. Performance vs. S&P 500 (VOO)

*   **TMDX Cumulative Return:** 242.47%
*   **VOO Cumulative Return:** 67.71%
*   **Absolute Spread (TMDX - VOO):** 174.76%
*   **Spread Range:** Min: -64.2, Max: 296.4, Current: 179.1
*   **Relative Spread:** 67.5

**Analysis:** TMDX has significantly outperformed the S&P 500 (VOO) over the tracked period. The current absolute spread is 174.76%. The relative spread of 67.5 indicates that the current performance is positioned in the upper-middle range relative to its historical deviation from the S&P 500.

#### Alpha, Beta Analysis

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2019-2021  | -4.0%  | 63.4% | -52.0%  | 0.0    | 0.7    |
| 2020-2022  | 140.0% | 68.3% | 138.0%  | 0.1    | 2.1    |
| 2021-2023  | 95.0%  | 69.4% | 77.0%   | 0.2    | 2.7    |
| 2022-2024  | 147.0% | 82.8% | 121.0%  | 0.2    | 2.1    |
| 2023-2025  | 124.0% | 82.8% | 76.0%   | 0.5    | 4.4    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) demonstrates strong growth in recent periods (2020-2025).
*   **MDD:** High Maximum Drawdown (MDD) figures indicate significant volatility and risk.
*   **Alpha:** Consistently high positive Alpha values suggest TMDX is generating returns above what would be expected based on market movements alone.
*   **Beta:** The Beta values are relatively low.
*   **Capital:** Market Cap shows growth, though fluctuations exist.

### 2. Recent Stock Price Movement

*   **Current Price:** \$129.19
*   **Last Market:** {'price': 129.19, 'previousClose': 127.69, 'change': 1.17}
*   **5-Day Moving Average:** 130.20
*   **20-Day Moving Average:** 133.96
*   **60-Day Moving Average:** 114.07

**Analysis:** The current price is slightly below the 5-day and 20-day moving averages, potentially indicating a short-term downward trend. However, it's significantly above the 60-day moving average, suggesting a stronger longer-term uptrend. The positive change in the last market indicates a recent rebound.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 35.79
*   **PPO:** -1.38
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35) (Cash Ratio: 69% on 2025-06-16)
*   **Recent Relative Spread Change (20-day):** -2.3 (Negative - Short-term decline)
*   **Expected Return (%):** 49.4

**Analysis:**

*   **MRI:** Indicates a low-risk environment.
*   **RSI:** The RSI of 35.79 suggests the stock may be approaching oversold conditions, potentially signaling a buying opportunity.
*   **PPO:** The negative PPO indicates a bearish short-term trend.
*   **Hybrid Signal:** The signal suggests a cautious approach, recommending a reduction in holdings and increased cash position due to concerns reflected in the MRI value.
*   **Recent Relative Spread Change:** The negative change suggests a recent underperformance relative to the S&P 500.
*   **Expected Return:** The high expected return (49.4%) suggests a positive long-term outlook for the stock, anticipating significant outperformance compared to the S&P 500.
*   **Last Market Impact:** The positive `change` value suggests a possible rebound or a short-term positive movement that may be associated with recent news.

### 4. Recent News & Significant Events

*   **2025-07-04:** Major business developments, regulatory changes, or market events.
*   **2025-07-01:** Analyst discussions on recent performance and outlook.
*   **2025-07-05:** Notable stock volatility.
*   **2025-07-03:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news indicates potential catalysts for volatility and performance shifts. Investors should closely monitor company announcements and industry trends.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 예상 EPS |
|------------|-------|---------|
| 2025-05-08 | 0.7   | 0.29    |
| 2025-02-27 | 0.19  | 0.22    |
| 2024-10-28 | 0.12  | 0.29    |
| 2024-07-31 | 0.35  | 0.21    |
| 2024-04-30 | 0.35  | 0.03256 |

**Analysis:** TMDX has consistently exceeded EPS estimates in recent quarters, suggesting strong financial performance and positive market sentiment.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | \$0.14B   | 61.47%        |
| 2024-12-31 | \$0.12B   | 59.21%        |
| 2024-09-30 | \$0.11B   | 55.94%        |
| 2024-06-30 | \$0.11B   | 60.59%        |
| 2024-03-31 | \$0.10B   | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-03-31 | \$0.27B   | 9.64%   |
| 2024-12-31 | \$0.23B   | 3.00%   |
| 2024-09-30 | \$0.21B   | 2.01%   |
| 2024-06-30 | \$0.19B   | 6.42%   |
| 2024-03-31 | \$0.16B   | 7.65%   |

**Analysis:**

*   **Revenue:** Revenue has been steadily increasing, indicating business growth.
*   **Profit Margin:** High and relatively stable profit margins suggest efficient operations.
*   **Equity:** Equity has been increasing, reflecting a strengthening financial position.
*   **ROE:** Return on Equity (ROE) fluctuates, with a recent high indicating good profitability relative to equity.

### 7. Overall Analysis & Conclusion

Transmedics Group Inc (TMDX) demonstrates strong historical outperformance compared to the S&P 500, driven by high growth rates and positive Alpha. While the stock exhibits significant volatility (high MDD), recent financial performance shows promising trends with increasing revenue, high profit margins, and growing equity.

Technical indicators suggest a potential short-term pullback (negative PPO, recent relative spread decline), but the RSI indicates that the stock may be approaching oversold conditions. The MRI suggests a low-risk environment. The Hybrid Signal encourages a cautious approach.

Recent news and earnings results highlight potential catalysts for volatility and continued growth. Given the high expected return (49.4%), TMDX appears to be a potentially attractive investment for long-term investors, but investors should carefully monitor the stock for volatility.
